Trial Profile
A retrospective observational study investigated effect of ceftaroline fosamil in patients with methicillin-resistant staphylococcus aureus (MRSA) boodstream infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Infections; Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 28 Oct 2015 New trial record
- 18 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy